Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2007-06-26
2007-06-26
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C514S313000
Reexamination Certificate
active
10066091
ABSTRACT:
A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer.
REFERENCES:
patent: 4983593 (1991-01-01), Miyajima et al.
patent: 5456923 (1995-10-01), Nakamichi et al.
patent: 5714506 (1998-02-01), Fisher et al.
patent: 5880095 (1999-03-01), Park et al.
patent: 5932587 (1999-08-01), Schmeck et al.
patent: 6069148 (2000-05-01), Schmidt et al.
patent: 6140342 (2000-10-01), Goldstein et al.
patent: 6140343 (2000-10-01), DeNinno et al.
patent: 6147090 (2000-11-01), DeNinno et al.
patent: 6197786 (2001-03-01), DeNinno et al.
patent: 6310075 (2001-10-01), DeNinno et al.
patent: 2001/0018446 (2001-08-01), Sikorski et al.
patent: 2001/0028895 (2001-10-01), Bisgaier et al.
patent: 2003/0054038 (2003-03-01), Crew et al.
patent: 2003/0091643 (2003-05-01), Friesen et al.
patent: 0299641 (1989-01-01), None
patent: 0344603 (1989-04-01), None
patent: 0580860 (1992-04-01), None
patent: 0796846 (1997-07-01), None
patent: 0801060 (1997-10-01), None
patent: 0818197 (1998-01-01), None
patent: 0818448 (1998-01-01), None
patent: 0 901 786 (1999-03-01), None
patent: 0901786 (1999-03-01), None
patent: 0992496 (2000-04-01), None
patent: 1020439 (2000-07-01), None
patent: 1160330 (2001-12-01), None
patent: 2305665 (1997-04-01), None
patent: 10287662 (1998-10-01), None
patent: WO 98/39299 (1998-09-01), None
patent: WO 99/14174 (1999-03-01), None
patent: WO 99/14204 (1999-03-01), None
patent: WO 99/14215 (1999-03-01), None
patent: WO 99/41237 (1999-08-01), None
patent: WO 00/17164 (2000-03-01), None
patent: WO 00/18721 (2000-04-01), None
patent: WO 00/18723 (2000-04-01), None
patent: WO 00/18724 (2000-04-01), None
patent: WO 00/72825 (2000-12-01), None
Toyoda et al. “Effect of Efonidipine hydrochloride (NZ-105). a new dihydropyridine calcium antagonist, on the experimental atherosclerosisin cholesterol fed rabbits,” in Japanese Journal of Pharmacoloy, vol. 103m Issue 5, May 1994, pp. 231-239.
Kitahara et al. “Effects of efonidipine hydrochloride on cholesterol esterification mediated by beta-very low density lipoprotein in J774 macrophages,” in Japanese Journal of Pharmacology, vol. 69, Issue 2, Oct. 1995, pp. 101-109.
Gordon, David J., Circulation, vol. 79, No. 1, Jan. 1989, pp. 8-15.
U.S. Appl. No. 10/459,808, filed Jun. 10, 2003.
U.S. Appl. No. 10/173,945 filed Jun. 17, 2002.
U.S. Appl. No. 09/495,061 filed Jan. 31, 2000.
U.S. Appl. No. 09/495,059 filed Jan. 31, 2000.
Bisgaler, et al., LIPIDS, vol. 29, No. 12, 1994.
Crew Marshall D.
Curatolo William J.
Friesen Dwayne T.
Gumkowski Michael Jon
Lorenz Douglas A.
Benson Gregg C.
Fubara Blessing
Hartley Michael G.
Jones James T.
Pfizer Inc
LandOfFree
Pharmaceutical compositions of cholesteryl ester transfer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of cholesteryl ester transfer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of cholesteryl ester transfer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872015